MARKET

SCNI

SCNI

Scinai Immunotherapeutics Ltd.
NASDAQ
0.5330
+0.0206
+4.02%
After Hours: 0.5431 +0.0101 +1.89% 18:51 05/12 EDT
OPEN
0.5166
PREV CLOSE
0.5124
HIGH
0.5700
LOW
0.5126
VOLUME
78.75K
TURNOVER
--
52 WEEK HIGH
6.18
52 WEEK LOW
0.4549
MARKET CAP
1.88M
P/E (TTM)
-0.1499
1D
5D
1M
3M
1Y
5Y
1D
Scinai Immunotherapeutics Sets June 16, 2026 Shareholder Meeting to Expand Share Capital and Approve Executive Incentives
TipRanks · 4h ago
Weekly Report: what happened at SCNI last week (0504-0508)?
Weekly Report · 1d ago
Scinai files to sell 16.34M American Depositary shares for holders
TipRanks · 4d ago
Scinai Immunotherapeutics Files Pro Forma Financials After February Acquisition of Recipharm Israel
TipRanks · 4d ago
Weekly Report: what happened at SCNI last week (0427-0501)?
Weekly Report · 05/04 09:06
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 04/27 21:05
Scinai Immunotherapeutics Raises $2.61 Million in ADS and Warrant Financing to Expand CDMO and Immunotherapy Programs
TipRanks · 04/27 20:47
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 04/27 17:05
More
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Webull offers Scinai Immunotherapeutics Ltd - ADR stock information, including NASDAQ: SCNI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNI stock methods without spending real money on the virtual paper trading platform.